AU2002224403A1 - Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use - Google Patents
Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of useInfo
- Publication number
- AU2002224403A1 AU2002224403A1 AU2002224403A AU2440302A AU2002224403A1 AU 2002224403 A1 AU2002224403 A1 AU 2002224403A1 AU 2002224403 A AU2002224403 A AU 2002224403A AU 2440302 A AU2440302 A AU 2440302A AU 2002224403 A1 AU2002224403 A1 AU 2002224403A1
- Authority
- AU
- Australia
- Prior art keywords
- endostatin
- angiogenesis
- protein kinases
- inhibiting peptides
- pitslre protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24012700P | 2000-10-13 | 2000-10-13 | |
US60/240,127 | 2000-10-13 | ||
PCT/US2001/032437 WO2002030982A2 (en) | 2000-10-13 | 2001-10-15 | Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002224403A1 true AU2002224403A1 (en) | 2002-04-22 |
Family
ID=22905218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002224403A Abandoned AU2002224403A1 (en) | 2000-10-13 | 2001-10-15 | Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020086007A1 (en) |
AU (1) | AU2002224403A1 (en) |
WO (1) | WO2002030982A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2815541B1 (en) * | 2000-10-24 | 2008-02-29 | Lipha | USE OF PERICYTE APOPTOSIS INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY |
WO2002067971A2 (en) | 2001-02-22 | 2002-09-06 | Novartis Ag | Use of endostatin in the treatment of ocular neovascularization |
US20070104684A1 (en) * | 2002-08-28 | 2007-05-10 | Campochiaro Peter A | Ocular gene therapy |
US7524811B2 (en) | 2003-08-29 | 2009-04-28 | Children's Medical Center Corporation | Anti-angiogenic peptides from the N-terminus of endostatin |
AU2004269399A1 (en) * | 2003-08-29 | 2005-03-10 | Children's Medical Center Corporation | Anti-angiogenic peptides from the N-terminus of endostatin |
EP2649095B1 (en) | 2010-12-10 | 2021-10-06 | Aleksander S. Popel | Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1202932A (en) * | 1995-10-23 | 1998-12-23 | 儿童医学中心公司 | Therapeutic antiangiogenic compositions and methods |
EP1147188B1 (en) * | 1999-01-26 | 2007-05-16 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Internal ribosome entry site (ires), vector containing same and the uses thereof |
AU2001238347A1 (en) * | 2000-02-28 | 2001-09-12 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
-
2001
- 2001-10-15 US US09/978,531 patent/US20020086007A1/en not_active Abandoned
- 2001-10-15 WO PCT/US2001/032437 patent/WO2002030982A2/en active Application Filing
- 2001-10-15 AU AU2002224403A patent/AU2002224403A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002030982A2 (en) | 2002-04-18 |
US20020086007A1 (en) | 2002-07-04 |
WO2002030982A3 (en) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002083921A8 (en) | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers | |
AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
AU1926001A (en) | Novel human protein kinases and protein kinase-like enzymes | |
AU5455900A (en) | Heart homing peptides and methods of using same | |
AU2001267475A1 (en) | Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof | |
AU8079901A (en) | Promyostatin peptides and methods of using same | |
WO2003059257A8 (en) | Anti-angiogenic proteins and fragmentsand methods of use thereof | |
AU2002255952A1 (en) | Short bioactive peptides and methods for their use | |
AU2002365404A1 (en) | Solid-phase immobilization of proteins and peptides | |
AU2002246808A1 (en) | Human nucleic acids and polypeptides and methods of use thereof | |
AU7748200A (en) | Hypoxia-related human genes, proteins, and uses thereof | |
AU2002343601A1 (en) | Proteins involved in regulation of adipocytes and uses related thereto | |
AU2002224403A1 (en) | Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use | |
AU2002365202A1 (en) | Synthetic genes for malarial proteins and methods of use | |
AU2001272932A1 (en) | Angiostatin and endostatin binding proteins and methods of use | |
AU2001234544A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
AU8542701A (en) | Stress proteins and peptides and methods of use thereof | |
AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
AU7846000A (en) | Novel human lipase proteins, nucleic acids encoding them, and uses of both of these | |
AU2001264934A1 (en) | Dna repair polypeptides and methods of use | |
AU2001266813A1 (en) | Human proteins and nucleic acids encoding same | |
AU5634400A (en) | Shank proteins and methods of use thereof | |
AUPQ599500A0 (en) | Novel peptides, modulatory agents therefor and methods of using them | |
AUPR595601A0 (en) | Hypoglycaemic peptides and methods of use thereof | |
AU5495500A (en) | Decorin binding protein essential peptides and methods of use |